Net Income (Loss) Attributable to Parent in USD of Fulgent Genetics, Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fulgent Genetics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2014 to Q3 2025.
  • Fulgent Genetics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$6,608,000.000, a 54.9% increase year-over-year.
  • Fulgent Genetics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$42,983,000.000, a 73.9% increase year-over-year.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$42,708,000.000, a 74.6% increase from 2023.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$167,825,000.000, a 217% decline from 2022.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $143,403,000.000, a 71.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Fulgent Genetics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$42,983,000 -$6,608,000 +$8,040,000 +54.9% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$51,023,000 -$18,957,000 -$10,247,000 -1.2% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 -$40,776,000 -$11,530,000 +$1,932,000 +14.4% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025
Q4 2024 -$42,708,000 -$5,888,000 +$122,261,000 +95.4% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 -$164,969,000 -$14,648,000 -$1,541,000 -11.8% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 -$163,428,000 -$8,710,000 +$2,519,000 +22.4% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025
Q1 2024 -$165,947,000 -$13,462,000 +$1,878,000 +12.2% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025
Q4 2023 -$167,825,000 -$128,149,000 -$104,317,000 -4.4% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 -$63,508,000 -$13,107,000 -$14,826,000 -8.6% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$48,682,000 -$11,229,000 -$22,766,000 -2% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$25,916,000 -$15,340,000 -$169,319,000 -1.1% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024
Q4 2022 $143,403,000 -$23,832,000 -$128,171,000 -1.2% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023
Q3 2022 $271,574,000 $1,719,000 -$120,803,000 -98.6% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $392,377,000 $11,537,000 -$68,275,000 -85.5% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $460,652,000 $153,979,000 -$46,712,000 -23.3% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 $507,364,000 $104,339,000 -$61,968,000 -37.3% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $569,332,000 $122,522,000 +$75,884,000 +1.6% 01 Jul 2021 30 Sep 2021 10-K 28 Feb 2023
Q2 2021 $493,448,000 $79,812,000 +$76,491,000 +23% 01 Apr 2021 30 Jun 2021 10-K 28 Feb 2023
Q1 2021 $416,957,000 $200,691,000 +$202,647,000 01 Jan 2021 31 Mar 2021 10-K 28 Feb 2023
Q4 2020 $214,310,000 $166,307,000 +$166,603,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $47,707,000 $46,638,000 +$45,176,000 +30.9% 01 Jul 2020 30 Sep 2020 10-K 28 Feb 2022
Q2 2020 $2,531,000 $3,321,000 +$2,990,000 +9% 01 Apr 2020 30 Jun 2020 10-K 28 Feb 2022
Q1 2020 -$459,000 -$1,956,000 -$48,000 -2.5% 01 Jan 2020 31 Mar 2020 10-K 28 Feb 2022
Q4 2019 -$411,000 -$296,000 +$1,757,000 +85.6% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2021
Q3 2019 -$2,168,000 $1,462,000 +$2,057,000 01 Jul 2019 30 Sep 2019 10-K 08 Mar 2021
Q2 2019 -$4,225,000 $331,000 +$1,380,000 01 Apr 2019 30 Jun 2019 10-K 08 Mar 2021
Q1 2019 -$5,605,000 -$1,908,000 +$2,000 +0.1% 01 Jan 2019 31 Mar 2019 10-K 08 Mar 2021
Q4 2018 -$5,607,000 -$2,053,000 -$429,000 -26.4% 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$5,178,000 -$595,000 +$498,000 +45.6% 01 Jul 2018 30 Sep 2018 10-K 13 Mar 2020
Q2 2018 -$5,676,000 -$1,049,000 -$1,024,000 -41% 01 Apr 2018 30 Jun 2018 10-K 13 Mar 2020
Q1 2018 -$4,652,000 -$1,910,000 -$2,142,000 -9.2% 01 Jan 2018 31 Mar 2018 10-K 13 Mar 2020
Q4 2017 -$2,510,000 -$1,624,000 -$2,437,000 -3% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019
Q3 2017 -$73,000 -$1,093,000 +$14,000 +1.3% 01 Jul 2017 30 Sep 2017 10-K 22 Mar 2019
Q2 2017 -$87,000 -$25,000 +$4,467,000 +99.4% 01 Apr 2017 30 Jun 2017 10-K 22 Mar 2019
Q1 2017 -$4,554,000 $232,000 +$834,000 01 Jan 2017 31 Mar 2017 10-K 22 Mar 2019
Q4 2016 -$5,388,000 $813,000 +$8,150,000 01 Oct 2016 31 Dec 2016 10-K 20 Mar 2018
Q3 2016 -$13,538,000 -$1,107,000 -$2,287,000 -1.9% 01 Jul 2016 30 Sep 2016 10-K 20 Mar 2018
Q2 2016 -$11,251,000 -$4,492,000 -$5,239,000 -7% 01 Apr 2016 30 Jun 2016 10-K 20 Mar 2018
Q1 2016 -$6,012,000 -$602,000 -$1,027,000 -2.4% 01 Jan 2016 31 Mar 2016 10-K 20 Mar 2018
Q4 2015 -$4,985,000 -$7,337,000 01 Oct 2015 31 Dec 2015 10-K 17 Mar 2017
Q3 2015 $1,180,000 01 Jul 2015 30 Sep 2015 10-K 17 Mar 2017
Q2 2015 $747,000 01 Apr 2015 30 Jun 2015 10-K 17 Mar 2017
Q1 2015 $425,000 01 Jan 2015 31 Mar 2015 10-K 17 Mar 2017

Fulgent Genetics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$42,708,000 +$125,117,000 +74.6% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$167,825,000 -$311,228,000 -2.2% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $143,403,000 -$363,961,000 -71.7% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $507,364,000 +$293,054,000 +1.4% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $214,310,000 +$214,721,000 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 -$411,000 +$5,196,000 +92.7% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$5,607,000 -$3,097,000 -1.2% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 -$2,510,000 +$2,837,000 +53.1% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019
2016 -$5,347,000 +$2,967,000 +35.7% 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2018
2015 -$8,314,000 -$4,031,000 -94.1% 01 Jan 2015 31 Dec 2015 10-K 17 Mar 2017
2014 -$4,283,000 01 Jan 2014 31 Dec 2014 10-K 17 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.